Replies

6) Vaccinated exponentially more likely to get re-infected with COVID: A new preprint study from Bangladesh found that among 404 people re-infected with COVID, having been vaccinated made someone 2.45 times more likely to get re-infected with a mild infection, 16.1 times more likely to get a moderate infection, and 3.9 times more likely to be re-infected severely, relative to someone with prior infection who was not vaccinated. Although overall re-infections were rare, vaccination was a greater risk factor of re-infection that co-morbidities!

Hence, the findings of this first-in-its-kind study harmonize with what a Public Health England survey found in October; namely, that the vaccines seem to erase a degree of N (nucleocapsid) antibodies generated by prior infection in favor of narrower S (spike) antibodies. "Recent observations from UK Health Security Agency (UKHSA) surveillance data that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination,” stated the week 42 report from the U.K. (p. 23).

This finding also correlates with what researchers from Mount Sinai in New York and Hospital La Paz in Madrid found last year – that the second dose of the vaccine “determines a contraction of the spike-specific T cell response." In that report, researchers already observed that other research has shown "the second vaccination dose appears to exert a detrimental effect in the overall magnitude of the spike-specific humoral response in COVID-19 recovered individuals."

At this point, how is there any benefit, much less a net benefit, from the shots? There are currently 21,000 deaths reported to VAERS, along with 110,000 hospitalizations and over 1 million total adverse events. Most deaths and injuries are never reported to VAERS. Now that the efficacy is, at best, a wash and at worst negative, why are we not discussing the short-term and long-term liabilities of the shots?

Remember, the VAERS numbers don’t even begin to quantify the long-term concerns, such as cancer and auto-immune diseases. A heavily redacted analysis of the Pfizer shot (p. 16) from the Australian Therapeutic Goods Agency (TGA) flatly conceded, “Neither genotoxicity nor carcinogenicity studies were performed.”

Consider the fact that the CEO of Indiana-based life insurance company OneAmerica, which has been around since 1877, revealed last week that the death rate among 18- to 64-year-old Hoosiers is up 40% from pre-pandemic levels. That is four times above what risk assessors consider catastrophic. Yes, some of this has been due to the virus, but given the age group, OneAmerica CEO Scott Davidson said that most of the claims for deaths being filed are not classified as COVID-19 deaths. Brian Tabor, the president of the Indiana Hospital Association, who spoke at the same news conference as Davidson, said that Indiana hospitals are flooded with patients “with many different conditions.” Any wonder what those ailments are if not COVID itself?

Indeed, those who say the injections are a “medical miracle” are correct, just not in the way they meant it.